SCHEDULE: Investment Funds Disclose Significant Stake in Reviva Pharmaceuticals
Beneficial Ownership Report
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly disclosed a 5.9% beneficial ownership stake in Reviva Pharmaceuticals Holdings, Inc., totaling 4,000,000 shares.
Summary
- CVI Investments, Inc. and Heights Capital Management, Inc. are jointly reporting beneficial ownership of 4,000,000 shares of common stock in Reviva Pharmaceuticals Holdings, Inc.
- This ownership represents 5.9% of the total class of securities outstanding.
- Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and exercises shared voting and dispositive power over these shares.
- The filing indicates that the shares were not acquired for the purpose of changing or influencing the control of Reviva Pharmaceuticals Holdings, Inc.
Sentiment
Score: 5
Explanation: The document is a neutral, factual disclosure of beneficial ownership, providing no direct positive or negative operational or financial news about the issuer.
Positives
- The disclosure of a significant institutional stake by CVI Investments, Inc. and Heights Capital Management, Inc. may signal confidence in Reviva Pharmaceuticals Holdings, Inc. from sophisticated investors.
Future Outlook
The document is a regulatory filing disclosing beneficial ownership and does not contain any forward-looking statements or guidance regarding the company's future performance or operations.
Management Comments
- Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc., certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing reflects a passive institutional investment by CVI Investments, Inc., managed by Heights Capital Management, Inc., in a pharmaceutical company. Such investments are common and indicate a fund's decision to hold a significant, non-controlling stake in a publicly traded entity within the healthcare sector.
Comparison to Industry Standards
- NA
Related Party Transactions
- Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and is formally granted limited power of attorney to enter into transactions on behalf and for the account of CVI Investments, Inc.
Stakeholder Impact
- Shareholders: The disclosure provides transparency regarding a significant institutional holder, which can influence market perception and potentially liquidity.
Next Steps
- The reporting persons will continue to file amendments to this Schedule 13G as required by SEC regulations if their beneficial ownership percentage changes significantly.
Key Dates
| Date | Description |
|---|---|
| July 16, 2015 | Limited Power of Attorney given by CVI Investments, Inc. to Heights Capital Management, Inc. |
| 06/26/2025 | Date of the event which required the filing of this statement; also the date of the Prospectus Supplement indicating shares outstanding. |
| 07/01/2025 | Date of signing the Schedule 13G and Joint Filing Agreement by Sarah Travis on behalf of CVI Investments, Inc. and Heights Capital Management, Inc. |
Keywords
Reviva Pharmaceuticals Holdings Inc., CVI Investments Inc., Heights Capital Management Inc., Schedule 13G, beneficial ownership, institutional investment, common stock, pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.